You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

Claims for Patent: 4,755,534

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 4,755,534

Title:	Propenylamines, pharmaceutical compositions containing them and their use as pharmaceuticals
Abstract:	A compound of the formula: ##STR1## wherein the double bond is in the trans configuration and R.sub.1 is a radical of formula IIa, ##STR2## R.sub.2, R.sub.3, R.sub.5, R.sub.7 and R.sub.8 are each hydrogen, R.sub.4 is methyl, and R.sub.6 is a radical of formula IIIa where R.sub.11 is n-butyl, tertiary butyl or phenyl or a chemotherapeutically acceptable acid addition salt thereof; processes for their production, their use as pharmaceuticals and pharmaceutical compositions containing them.
Inventor(s):	Stuetz; Anton (Maria Enzersdorf, AT)
Assignee:	Sandoz Ltd. (Basel, CH)
Application Number:	06/646,724
Patent Claims:	1. A compound of the formula: ##STR78## wherein the double bond is in the trans configuration and R.sub.1 is a radical of formula IIa, ##STR79## R.sub.2, R.sub.3, R.sub.5, R.sub.7 and R.sub.8 are each hydrogen, R.sub.4 is methyl, and R.sub.6 is a radical of formula IIIa where R.sub.11 is n-butyl, tertiary butyl or phenyl or a chemotherapeutically acceptable acid addition salt thereof. 2. The trans compound according to claim 1 in which R.sub.1 is 1-naphthyl, R.sub.2 and R.sub.3 are H; R.sub.4 is CH.sub.3, R.sub.5 is H, and R.sub.6 is --C.tbd.C--C.sub.6 H.sub.5. 3. N-Methyl-N-(1-naphthylmethyl)-non-2(trans)en-4-ynyl-1-amine or a chemotherapeutically acceptable acid addition salt thereof. 4. N-Methyl-N-(1-naphthylmethyl)-6,6-dimethylhept-2(trans)-e n-4-ynyl-1-amine or a chemotherapeutically acceptable acid addition salt thereof. 5. A compound as claimed in claim 1 in the form of its hydrochloride. 6. A chemotherapeutical composition comprising an effective amount of a compound as claimed in claim 1 or a chemotherapeutically acceptable acid addition salt thereof in admixture with a chemotherapeutically acceptable diluent or carrier. 7. A method of treating diseases or infections caused by mycetes which comprises administering to a subject in need of treatment an effective amount of a compound as claimed in claim 1 or a chemotherapeutically acceptable acid addition salt thereof.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.